METROPOLITAN LIFE INSURANCE CO/NY - MONTE ROSA THERAPEUTICS INC ownership

MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 58 filers reported holding MONTE ROSA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of MONTE ROSA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,718
-30.1%
1,8200.0%0.00%
-100.0%
Q2 2023$12,467
-12.1%
1,8200.0%0.00%0.0%
Q1 2023$14,178
-12.4%
1,820
-14.4%
0.00%0.0%
Q4 2022$16,186
-6.9%
2,1270.0%0.00%0.0%
Q3 2022$17,378
-15.5%
2,1270.0%0.00%0.0%
Q2 2022$20,568
-31.0%
2,1270.0%0.00%0.0%
Q1 2022$29,821
-62.8%
2,127
-40.9%
0.00%0.0%
Q3 2021$80,1633,5980.00%
Other shareholders
MONTE ROSA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,472,331$11,204,4397.40%
NEA Management Company, LLC 7,692,298$58,538,3883.29%
Cormorant Asset Management, LP 2,893,717$22,0211.47%
Alphabet Inc. 1,464,015$11,141,1540.65%
Avoro Capital Advisors LLC 4,325,000$32,913,2500.49%
Casdin Capital, LLC 510,882$3,887,8120.30%
RTW INVESTMENTS, LP 1,214,572$9,242,8930.19%
Virtus Investment Advisers, Inc. 12,638$96,1750.06%
Woodline Partners LP 511,351$3,891,3810.05%
CORNERCAP INVESTMENT COUNSEL INC 28,192$214,5410.04%
View complete list of MONTE ROSA THERAPEUTICS INC shareholders